Dr. Reddy's in News

  • Business World Business World
    23rd August, 2013

    India's Most Respected Companies
    Dr. Reddy’s is India's Most Respected Pharmaceutical Company

    Click Here for the Complete Story[PDF Format]
  • ISB Insight ISB Insight
    12nd August, 2013

    Organic and Inorganic Internationalisation: Insights From Dr Reddy’s
    Dr. Reddy's Laboratories (DRL) was promoted in 1984 by Anji Reddy, a pioneering scientist-entrepreneur

    Click Here for the Complete Story[PDF Format]
  • Outlook Business Outlook Business
    2nd August, 2013

    Reinventing Dr. Reddys
    GV Prasad and Satish Reddy are continuing the legacy of Anji Reddy with a new blueprint to suit changing industry dynamics

    Click Here for the Complete Story[PDF Format]
  • Mint Mint
    9th July 2013

    Dr. Reddy's to focus on Eurpore and India markets
    GV Prasad says firm investing in capabilities in advance to ensure there are no regulatory problems

    Click Here for the Complete Story [PDF Format]
  • The Economic Times The Economic Times
    10th July 2013

    Falling Standards Pharma's Bane: Dr Reddy's Boss
    GV Prasad says Increased scrutiny is good for industry and will help get its act together.

    Click Here for the Complete Story [PDF Format]
  • Forbes India Forbes India
    19th June 2013

    GV Prasad: You can never have a company totally dependent on one person
    When I came back to india after graduation in the us, I knew I wanted to start a business but what that would be I didn’t know.

    Click Here for the Complete Story [PDF Format]
  • Business Standard Business Standard
    5th April 2013

    A natural choice for Dr Reddy’s
    G V Prasad’s elevation this week as the chairman of Dr Reddy’s Laboratories has not come as a surprise to those in the industry.

    Click Here for the Complete Story [PDF Format]
  • The Economic Times The Economic Times
    17th March 2013

    Man who introduced India to drug called innovation
    Dr Kallam Anji Reddy, founder of Hyderabad-based drugmaker Dr Reddy's Laboratories (DRL) and pioneering pharma entrepreneur who passed away on March 15, loved a challenge.

    Click Here for the Complete Story [PDF Format]
  • The Hindu - Business Line The Hindu - Business Line
    17th March 2013

    Pharma’s free radical
    Anji Reddy's commitment to research and affordable medicine was extraordinary.

    Click Here for the Complete Story [PDF Format]
  • Entrepreneur India Entrepreneur India
    1st Septmeber, 2012

    Grab the opportunity when it comes
    It is time for beneficiaries of liberalization to lead

    Click Here for the Complete Story[PDF Format]
  • Business Standard Business Standard
    9th August, 2012

    Dr. Reddy's prescription to stay ahead of the generic pack
    The company has differentiated itself by focusing on internal processes and staying away from costly acquisitions. Now, it has other plans to fend off the competition.

    Click Here for the Complete Story[PDF Format]
  • Outlook Business Outlook Business
    4th August, 2012

    A new prescription
    Tectonic changes in the US generic drugs market is causing huge shifts in Indian pharma’s strategies as well.

    Click Here for the Complete Story[PDF Format]
  • The Hindu Hindu Business Line
    13th July, 2012

    Influence is a leadership tool
    Leaders can garner respect from others and achieve set targets by effectively influencing colleagues (by Saumen Chakraborty - President and Global Chief of Quality, HR& IT at Dr. Reddy’s Laboratories Ltd).

    Click Here for the Complete Story[PDF Format]
  • The Times Of India The Times Of India
    30th June, 2012

    Affordable innovative drugs still our priority
    For Satish Reddy, joining Dr Reddy's Labs (DRL) was not a planned move, and certainly not for which he was being groomed formally.

    Click Here for the Complete Story[PDF Format]
  • The Economic Times The Economic Times
    14th May, 2012

    Dr. Reddy’s chalks out plan to improve India performance
    India's second largest pharmaceutical company, dr. Reddy's Laboratories, is on the verge of giving final touches to a comprehensive strategy to boost the much needed growth in the Indian market

    Click Here for the Complete Story[PDF Format]
  • Business Today Business Today
    13th May, 2012

    Leaderspeak – GV Prasad

    Click Here for the Complete Story[PDF Format]

  • DNA Money DNA Money
    12th May 2012

    Dr. Reddy’s lines up strong drug pipeline
    Pharmaceuticals major Dr. Reddy’s Laboratories sees a busy year ahead as it plans to launch 15-16 products in the US market, which is likely to contribute one-third to its revenues.

    Click Here for the complete Story[PDF Format]
  • Chicago Tribune Chicago Tribune
    03rd May 2012

    India’s Dr. Reddy’s gets US nod for osteoporosis drug
    Indian drugmaker Dr Reddy's Laboratories has received U.S. Food and Drug Administration's approval for selling ibandronate sodium tablets used to treat osteoporosis, the regulator's website showed on Thursday.

    Click Here for the complete Story[PDF Format]
  • Scrip Intelligence SCRIP Intelligence
    27th April 2012

    Dr Reddy's plans multi-pronged strategy to build Russian business
    Dr. Reddy's appears set for a significant scale-up in Russia, including plans for a joint venture manufacturing facility, a prescription and OTx (prescription plus switch over-the-counter) thrust and a new in-licensing pact with Novartis deepening its engagement with one of its core international markets.

    Click Here for the complete Story[PDF Format]
  • Business Standard Business Standard
    20th April 2012

    Dr. Reddy's to replace DLF in Sensex
    The Bombay Stock Exchange (BSE) said today that pharma major Dr Reddy's Laboratories will replace DLF in the benchmark 30-share Sensex.

    Click Here for the Complete Story [PDF Format]
  • The Hindu The Hindu
    18th April 2012

    SMT is an empowered Multi-skilled and energetic team
    Developing an internal talent pool is important for organizations as it represents significant savings in terms of costs and on boarding time.

    Click Here for the Complete Story [PDF Format]
  • The Wall Street Journal The Wall Street Journal
    12th March, 2012

    Dr Reddy's: May Change Hedging Policy If Dollar Rises Sharply
    Dr. Reddy's Laboratories Ltd. may consider revising its hedging policy if the U.S. dollar gains sharply above the upper end of the Indian generic drug maker's expectations, its chief financial officer said.

    Click Here for the Complete Story[PDF Format]
  • The Wall Street Journal The Wall Street Journal
    24th February, 2012

    Career Journal: Hey Boss! Don't Assume Your Top Performers Are Happy
    Can good performance be taken as a parameter to judge an employee’s happiness? Not really, says Saumen Chakraborty, president and global chief of human resources, quality and information technology at Dr. Reddy’s Laboratories Ltd.

    Click Here for the Complete Story[PDF Format]
  • Business Today Business Today
    19th February, 2012

    In Good Health
    Anji Reddy may be unwell. But with a succession plan in place, no one is worried about the future of the company he founded

    Click Here for the Complete Story[PDF Format]
  • The Hindu The Hindu - Business Line
    24th January 2012

    Stage set for easy money
    We are returning to a phase of more predictability, and things have improved on the inflation front.

    Click Here for the Complete Story [PDF Format]
  • Scrip Intelligence SCRIP Intelligence
    6th January 2012

    Dr. Reddy's eyes biosimilars expansion and rejigs research focus
    Dr. Reddy's is in talks with potential partners to push into regulated markets in the biosimilars segment.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    30 October, 2011

    Wrong Prescription
    Providing access to quality health care should be the real concern, not the perceived impact of FDI on drug prices

    Click Here for the Complete Story[PDF Format]
  • The Economic Times The Economic Times
    13 October, 2011

    Beyond the patent cliff
    It is not just Big Pharma that has to prepare for life after the 'patent cliff': patent expiries on a slew of blockbuster drugs. Leading Indian generics companies do too. According to one estimate, the value of drugs going off-patent between 2016 and 2020 will fall 62% from the value in the preceding five-year period (2011-15). For Indian companies, this means a smaller opportunity in their main business: off-patent drug exports. They will need other drivers to grow. ET breaks down four key growth drivers that could kick in around the same time for them.

    Click Here for the Complete Story[PDF Format]
  • Reforms 2020 Reforms 2020
    October, 2011

    TOP 20 ENTREPRENEURS
    Interview with Saumen Chakraborty, Global Chief of HR, Dr. Reddy's, Cover Column

    Click Here for the Complete Story[PDF Format]
  • The Human Factor The Human Factor
    September, 2011

    Unbaised Exchange
    Interview with Saumen Chakraborty, Global Chief of HR, Dr. Reddy's, Cover Column

    Click Here for the Complete Story[PDF Format]
  • People Matters People Matters
    19 August, 2011

    Learning Curve
    Cover Story Interview: GV Prasad, Chief Executive Officer and Vice Chairman, Dr. Reddy's Laboratories

    Click Here for the Complete Story[PDF Format]
  • Outlook Business Outlook Business
    11 June, 2011

    The Responsible way
    Starting out as an employee of a state-owned Indian Drugs And Pharmaceuticals in 1969, Dr. K Anji Reddy is known today not only as the Founder Chairman of Dr. Reddy's Laboratories but also for his work as the Chairman of Naandi Foundation and Dr. Reddy’s Foundation - institutions that have done commendable social work.

    Click Here for the Complete Story[PDF Format]
  • The Financial Express The Financial Express
    20 May, 2011

    The Drug Crusader
    Driven by a distinctive generics product portfolio and its own yet-to-be-discovered medicines, Dr. K Anji Reddy shares his thoughts with The Financial Express on the Dr. Reddy's becoming one of the best innovation engines from this part of the world

    Click Here for the Complete Story[PDF Format]
  • The Economic Times The Economic Times
    3 May, 2011

    Cure for Clean water
    Naandi Community Water Services for providing purifying water in villages, interview with Dr. K Anji Reddy, Chairman, Naandi Foundation

    Click Here for the Complete Story [PDF Format]
  • The Economic Times The Economic Times
    3 May, 2011

    A Capitalist's Guide to Social Business
    A market based approach to philanthropy, with one eye firmly on the bottom line, can be an effective way for enterpreneurs to meet their social goals.

    Click Here for the Complete Story [PDF Format]
  • Outlook - Business
    The Economic Times
    21 April, 2011

    The Unfinished Agenda
    In the 1980s, he founded what would become India's second-largest generics pharma company, In the 1990s, he pionered new drug discovery in the country. In the 2000s, he sparked a mission to provide safe drinking water to all Indian villages. Yet, far from hanging up his boots, Kallam Anji Reddy is just about getting started.

    Click Here for the Complete Story [PDF Format]
     
  • Outlook - Business Outlook - Business
    5 March, 2011

    Passing Down The Wisdom
    Three father-son duos of vulnerable business families share lessons learnt from the liberation era.

    Click Here for the Complete Story [PDF Format]
  • Forbes India Forbes India
    28 January, 2011

    Dr. Reddy's Is Back: The Drug Maker's New Avatar
    Dr. Reddy's Returns: Dr. Reddy's Rejuvenation After a bad fall, Dr. Reddy's Laboratories is headed for a turnaround. Audacity pushed it from its perch as one of India's top drug makers. Realism is helping it make a comeback.

    Click Here for the Complete Story [PDF Format]
  • The Economic Times The Economic Times
    21 September, 2010

    No Indian pharma firm is tier-I: Dr. Reddy's CEO
    Vice-chairman and CEO, GV Prasad, talks about the strengths and weaknesses of the domestic pharma industry, the challenges facing DRL, its $3-billion target and the government's thoughts on FDI in pharma, in a candid conversation with ET.

    Click Here for the Complete Story [PDF Format]
  • Deccan Chronicle Deccan Chronicle - Business
    22 February 2010

    Father, scientist, pharma czar
    Dr. Reddy’s Labs, the first private enterprise that took pharma MNCs head on, will shortly celebrate its silver jubilee, Dr. Anji Reddy and his son Satish Reddy talk exclusively to Deccan Chronicle about the remarkable journey of the largest Indian pharma firm.

    Click Here for the Complete Story [PDF Format]
  • The Hindu The Hindu - Business Line
    19 February 2010

    Reddy Formula:
    25 years of robust, healthy way of doing business.

    Click Here for the Complete Story [PDF Format]
  • Business World Business World
    August 31, 2009

    Dr. Reddy's next Lab:
    Dr. K Anji Reddy, Founder Chairman, intends to provide purified drinking water to villagers across India by 2020.

    Click Here for the Complete Story [PDF Format]
  • India Today
    India Today
    August 24, 2009

    Jobs over Degrees:
    GV Prasad, Vice Chairman and CEO, talks about what it will take to transform the youth of India and create livelihood across the spectrum

    Click Here for the Complete Story [PDF Format]
  • Business India Business India
    May 31, 2009

    Innovating business models
    Guest Column by: GV Prasad, Vice-Chairman & CEO Dr. Reddy’s

    Serving non-traditional markets through innovation is success too.

    Click Here for the Complete Story [PDF Format]
  • Financial Express Financial Express
    9th April, 2009

    BEYOND THE BOARD
    ‘Entrepreneurship fuels innovation’

    The first and the last word for the 41-year-old Satish Reddy is to provide affordable healthcare needs with personal commitments. Perhaps, this dictum helped the managing director and chief operating officer of NYSE-listed Dr Reddy’s Laboratories to be recognised as a Young Global Leader 2007 by the World Economic Forum.

    Click Here for the Complete Story [HTML Format]
  • Financial Express Financial Express
    27th October, 2008

    Sustainability is mandatory for business survival
    Interview: GV Prasad, Vice-Chairman & CEO Dr. Reddy’s

    Dr Reddy’s Laboratories is a leader in more ways than one. The company has a lesser-known distinction of being the first pharma company in India to publish a sustainability report. Last week the com-pany released its fifth annual report with the theme The Journey of Sustainability. GV Prasad, vice-chairman and chief executive officer, talks about the report and the company’s philosophy on sustainability in an email interview with the FE

    Click Here for the complete Story[HTML Format]
  • The Economic Times The Economic Times
    September 29, 2008

    Helping hand of a medicine man

    Just what constitutes the idea of a Corporate Citizen? Is it a company's CSR (corporate social responsibility) initiatives or does it entail an ethical way of doing business... And the honour went to Dr Reddy's Foundation (DRF), the CSR arm of Dr Reddy's Labs.

    Click Here for the complete Story[HTML Format]
  • Business Week Business Week
    March 17, 2008

    Dr. Reddy's Mode of Discovery

    The Indian drugmaker's CEO explains the company's move from generic offerings, and its intent on securing a spot among the world's top 25 pharma companies.

    Click Here for the complete Story[HTML Format]
  • Bio Spectrum Bio Spectrum
    March, 2008

    Top 20 Life Sciences Institutes of India

    Being the most cost effective and compliant contract manufacturing hub (for pharmaceuticals) in Asia, Indian CMO's are now becoming more innovative, diversified and are adopting state-of-the-art process technology and international standards to stay competitive.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    March, 2008

    Meet Anji Reddy, The Philanthropist

    The Chairman of Dr. Reddy's Labs is morphing into one of India's most committed givers. Dr. Reddy's eponymous founder in now attacking social problems.

    Click Here for the complete Story[PDF Format]
  • Bio Spectrum Bio Spectrum
    March, 2008

    Dr. Reddy's aims to be a Biosimilar leader

    DHyderabad-based, Dr. Reddy's Laboratories, the $1.2 billion Indian Pharma major, and one of the world's leading generics players, is making determined efforts to increase its portfolio of biosimilar products and become a global leader in the next decade in this space. A spacial report from the company's Hyderabad campus.

    Click Here for the complete Story[PDF Format]
  • Outlook - Profit Outlook - Profit
    March, 2008

    There are plenty of opportunities in emerging markets

    Dr. Reddy's Laboratories' COO and MD Satish Reddy lays out his plans to take one of India's biggest pharmaceutical companies to the next level of growth.

    Click Here for the complete Story[PDF Format]
  • Global Logistics & Supply Chain Strategies Global Logistics & Supply Chain Strategies
    February, 2008

    TGeneric Drug Manufacturer's Supply Chain Ills

    Triple-digit growth rates, regulatory issues and the highly competitive nature of the generic drug market posed complexity issues for this India-based pharmaceutical company. UPS Supply Chain Solutions helped Dr. Reddy's sort it all out.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    January 27, 2008

    Trials by Fire

    Pharma entrepreneurs like Ajay Piramal and Anji Reddy are betting on drug discovery to double the industry's value to $129 billion by 2015.

    Click Here for the complete Story[PDF Format]
  • Money Today Money Today
    December 27, 2007

    From Babu to Corporate Honcho

    Career as Asset - Case Studies of successful career switches Prabir Jha's career focus did not waver nor did his professional plans go awry after quitting his cushy government job.

    Click Here for the complete Story[PDF Format]
  • Business India Business India
    December 16, 2007

    Betting on biotech

    Dr. Reddy's is concentrating now on biotechnology-based products and going for acquisitions to provide a base for launching them

    Click Here for the complete Story[PDF Format]
  • Ethical Corporation Ethical Corporation
    October 2007

    Targeting the poor sweetens the profits pill

    Indian pharma multinational Dr Reddy’s chief executive G V Prasad says that patient needs and shareholder value go hand-in-hand.

    Click Here for the complete Story[PDF Format]
  • PharmaTech.com PharmaTech.com
    September 2, 2007

    Leading the Pack - Lessons learned from the Top

    Life isn't so relaxing at the top. Ranking first among Indian pharmaceutical companies, Dr. Reddy's Laboratories (Hyderabad) is in itself a model that a lot of companies in the Indian industry have either drawn inspiration from or at best imitated.

    Click Here for the complete Story[HTML Format]
  • Business Today Business Today
    November 18, 2007

    The Best Companies to work for in India

    A BT-Mercer-TNS survey of India's best employers

    Click Here for the complete Story[PDF Format]
  • Los Angeles Times Los Angeles Times
    June 9, 2007
    Similarities in consumer bases help make the region a natural market.

    Meet Anji Reddy, The Philanthropist

    Ask for directions to Dr. Reddy's Laboratories Ltd. in this industrial city in central Mexico and locals will give you a curious look.Many are unfamiliar with the drug maker, one of India's largest pharmaceutical companies, which purchased a production facility here in late 2005 for about $59 million.

    It may be the first time they've heard of an Indian company doing business in Mexico, but it won't be the last.

    Click Here for the complete Story[HTML Format]
  • Rediff News Rediff News
    June 12, 2007

    Dr Reddy's: From Rs 25 lakh to Rs 5,800 crore

    The Patents Act signalled the arrival of good times for the pharmaceutical companies. Soon after the Act was announced, hundreds of companies started reverse engineering of western pharmaceutical products. There was a virtual explosion in the pharma space, with entrepreneurs making most of this opportunity.

    Click Here for the complete Story[PDF Format]
  • Outlook - Business Outlook - Business
    May 5, 2007

    Globe, A Place For You and Me

    Building global firms may not always be a stuff of fairy tales. Stick to a few basic principles, most often, you're there. Dr. Reddy's has a story for corporations looking for an international footprint.

    GV Prasad Vice Chairman & CEO, Dr. Reddy's Laboratories

    Click Here for the complete Story[PDF Format]
  • Newsweek International Newsweek International
    March 2007

    Foe Turned Friend

    Indian generic-drug makers once bedeviled Big Pharma; now they may be its best hope for success.

    Click Here for the complete Story[HTML Format]
  • Modern Pharmaceuticals Modern Pharmaceuticals
    February - March 2007

    Leaders Speak Dr. K. Anji Reddy.

    "Building a global generic business and increasing geographical expansion are key priorities for us"

    Click Here for the complete Story[PDF Format]
  • Bloomberg Markets Bloomberg Markets
    January 2007

    Dr. Reddy's Pfizer Fixation

    Special feature on Dr. Reddy's Labs

    India's maker of generic Prozac and Cipro, stung by flops and failed patent challenges, is staking its future on its founder's quest to create a homegrown blockbuster drug.

    Click Here for the complete Story[PDF Format]
  • Outlook - Business Outlook - Business
    December 5, 2006

    Carry on, Dr Reddy

    Special feature on Dr. Reddy's Labs

    The good times have started to roll for the pharma major, thanks to some big generic orders, acquisitions and research breakthroughs, but sustainability is what counts.

    Click Here for the complete Story[PDF Format]
  • INDIA TODAY INDIA TODAY
    December, 2006

    "First Person" with Dr.K.Anji Reddy, Chairman"


    Click Here for the complete Story[PDF Format]
  • Business World Business World
    November 20, 2006

    "First Person" with Dr.K.Anji Reddy, Chairman

    Indian companies and boutique western firms are forming research alliances that could challenge Big Pharma.

    Click Here for the complete Story[PDF Format]
  • Business World Business World
    November 13, 2006

    Dr. Reddy's on a high.

    Click Here for the complete Story[PDF Format]

  • Business Today Business Today
    November 5, 2006

    The Best Companies to work for in India

    A BT-Mercer-TNS survey of India's best employers

    The good times have started to roll for the pharma major, thanks to some big generic orders, acquisitions and research breakthroughs, but sustainability is what counts.

    Click Here for the complete Story[PDF Format]
  • THE WEEK THE WEEK
    September 24, 2006

    Most awaited Drugs

    Indian companies get ready to serve better and cheaper medicines for asthma to cardiocare and cancer.

    Click Here for the complete Story[PDF Format]
  • FOCUS Reports FOCUS Reports
    July, 2006

    Exclusive Interviews - Dr.K.Anji Reddy, Chairman

    March, 2006
    Exclusive Interviews - Mr.G.V.Prasad, CEO &Vice-Chairman

    Click Here for the complete Story[PDF Format]
  • Express Pharma Express Pharma
    16 - 30 June, 2006

    Winners Chronicle
    Pharma Excellence Awards 2006


    Click Here for the complete Story[PDF Format]
  • Business world Businessworld
    June 19, 2006

    "The Race to create India's first new drug" - Dr. Reddy's diabetes drug is entering the final phase of clinical trials. Three other Indian companies have molecules in advanced phases of testing. They aim to hit the market as early as 2009.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    May 21, 2006

    " Back In The Reckoning" - Some smart derisking strategies, a pick up in international markets and better prospects in the US have boosted Dr Reddy’s earning and stock, making it the hot pharma stock that it once was.

    Click Here for the complete Story[PDF Format]
  • Businessworld Businessworld
    May 15, 2006

    "The $50 – billion Opportunity" -Ranbaxy and Dr. Reddy’s may have found the formula for cracking the US generics market.

    Click Here for the complete Story[PDF Format]
  • Businessworld Businessworld
    May 01, 2006

    "This combination fits perfectly" - EUROPE has emerged as a lucrative hunting ground for Indian pharmaceutical companies. Last month, Dr. Reddy’s acquired betapharm, Germany’s third-largest generics company.

    Click Here for the complete Story[PDF Format]
  • Scrip Magazine Scrip Magazine
    April, 2006

    "Great minds think alike" - Observers will note clear parellels between Malvinder Singh and Satish Reddy's young business lives - both US-educated, the men have quickly risen to the top of two Indian pharma giants.

    Click Here for the complete Story[PDF Format]
  • India Today India Today
    April 03, 2006

    "Prescription for Success" - With the Rs 2,500 crore takeover of a top German pharma firm, Dr Reddy’s Laboratories not only ensures a strategic global presence, but also enters the top-three league on home ground.

    Click Here for the complete Story[PDF Format]
  • Businessworld Businessworld
    April 03, 2006

    "Compound Cure" - The world's first polypill, a multiple product pill for heart ailments, has been developed by Dr.Reddy's.

    Click Here for the complete Story[PDF Format]
  • Businessworld Businessworld
    March 20, 2006

    "Europe Ahoy!" - Dr. Reddy’s Laboratories acquires betapharm, Germany’s fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company.

    Click Here for the complete Story[PDF Format]
  • International Herald Tribune International Herald Tribune
    February 16, 2006

    "Dr. Reddy's is expanding into Europe" - The Indian drug maker Dr. Reddy's Laboratories said Thursday that it would buy Betapharm Arzneimittel for E480 million to expand in Germany, Europe's biggest pharmaceutical market.

    Click Here for the complete Story[HTML Format]
  • Management Scope Management Scope
    February, 2006

    "Family companies form the back bone of the Indian economy." - This is true for the pharma industry too. At medicine maker Dr. Reddy's - the father, son and son-in-law sit at the governing board table. Their most formidable challenge being Alliances with Western companies. (article in Dutch)

    Click Here for the complete Story[PDF Format]
  • BusinessWeek.com BusinessWeek.com
    February 08, 2006

    "Generics Make a Name for Themselves" - In an otherwise lackluster pharma market, stocks like Dr. Reddy's Labs are surging. With a slather of patents set to expire, their prospects look good.

    Click Here for the complete Story[HTML Format]
  • Chemical & Engineering News Chemical & Engineering News
    January 30, 2006

    "Dr.Reddy's gambit" - Frequent drug industry nemesis seeks to boost its custom manufacturing business.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    December 04, 2005

    The Long-Term Rx - If indian pharma's frontline leaders are not looking good, consider it as a short-term bottomline blip. With smart partnerships, b product pipelines and a tight control on costs, the future is definitely not break.

    Click Here for the complete Story[PDF Format]
  • BusinessWeek.com BusinessWeek.com
    November 30, 2005

    The Other Disease Plaguing Asia - Avian flu may get the headlines, but the health risks from diabetes are more severe. Help may come from India's and China's pharmas

    Click Here for the complete Story[PDF Format]
  • Chemical & Engineering News Business Today
    October 23, 2005

    Drugs that talk - Dr. Reddy's Labs signs another innovative deal, this time for discovery and development

    Click Here for the complete Story[PDF Format]
  • Business India Business India
    October 10 - 23, 2005

    Pillar to success - This year Dr Reddy's Laboratories completes five years of its Chinese Joint venture operations, Kunsham Rotam Reddy Pharmaceutical Co Limited (KRRP).

    Click Here for the complete Story[PDF Format]
  • CNN.com CNN.com
    September 07, 2005

    Imitate gives way to "innovate" - India's pharmaceutical industry increasingly turning to research - A CNN Report

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    August 28, 2005

    Riding Out Of: Things are looking up at Dr Reddy's Labs. First quarter profits are up and the stock has gained some of the lost ground . Finally, the worst may be behind the pharma major.

    Click Here for the complete Story[PDF Format]
  • India Today India Today
    August 22, 2005

    Search Engines: "India has an opportunity in R&D if we think out of the box. In each problem, there is an opportunity."

    Kallam Anji Reddy, Chairman, DRL

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    July 31, 2005

    Portal of Hope: In the six years since it was set up, Dr. Reddy's Foundations' Livelihood Advancement Business School has helped prepare some 35,000 underpriviledged youngsters for entry-level jobs.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    India Inc: Going Global
    Collector's Edition Volume II
    March , 2005

    India Inc: Going Global - CEOs from leading Indian companies shares their views.

    GV Prasad, Executive Vice Chairman and CEO, Dr. Reddy’s Laboratories, shares his thoughts on the company's 'Globalisation Journey'.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    December 04, 2005

    The Long-Term Rx - If indian pharma's frontline leaders are not looking good, consider it as a short-term bottomline blip. With smart partnerships, b product pipelines and a tight control on costs, the future is definitely not break.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    November 21, 2004

    The best companies to work for in India

    Dr. Reddy's is rated number seven across all sectors and the only pharmaceutical company to make the grade …

    Click Here for the complete Story[PDF Format]
  • Business World Business World
    November 8, 2004

    India's most respected companies

    Dr. Reddy's is rated number six across all sectors and number one in the pharmaceutical sector …

    Click Here for the complete Story[PDF Format]
  • businessworldindia www.businessworldindia.com
    November 8, 2004

    An interview with Dr. Uday Saxena, chief scientific officer, Dr. Reddy’s. Click Here for the complete Story[PDF Format]
  • CFO Asia CFO Asia

    India's generic-drug companies make an audacious bid for global recognition.

    Click Here for the complete Story[HTML Format]
  • Business World Business World
    August 16, 2004

    A Point to Prove
    Dr. Reddy's is sticking to its innovation-led strategy …

    Click Here for the complete Story[PDF Format]
  • Chemical & Engineering News Business Today
    India Inc : Going Global, Collector's Edition Volume I
    May, 2004

    The Indian MNCs
    While Dr. Reddy's wants to boost its generics and bulk drugs business, its long-term focus is on developing new drugs of its own.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    February 15, 2004

    India’s Journey to Becoming A Developed Nation Dr. Anji Reddy's recipe to make India a developed economy. Click Here for the complete Story[PDF Format]
  • Business World Business World
    August 27, 2003

    Free to Experiment
    Its all about giving every employee the space to do his own thing.

    Click Here for the complete Story[PDF Format]
  • Industry2 Industry2
    August, 2003.

    A well-researched approached

    It was only a year ago that Dr. Reddy's (DRL) was selected by Forbes Global in its "Best under a Billion, Forbes Global Best Small companies for 2002". It was the second consecutive year for the company....

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    Collector's Edition Volume IV, 2003.
    The New Paradigm Shift

    Innovation & Globalisation
    Mr GV Prasad, CEO, Dr. Reddy's elaborates on how innovation & entrepreneurship have driven the globalisation efforts of the company. Click Here for the complete Story[PDF Format]
  • Indian Management Indian Management
    July, 2003.

    Bringing Innovation to Social Goals
    The Dr. Reddy's Foundation for Human and Social Development brings innovation and entrepreneurship to the business of focussing on children and youth at risk among the urban poor.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    June 22, 2003

    India's Best Managed Companies
    Timely manoeuvres have made it the most innovative company in the industry. And its bid to be a billion-dollar pharma major in another five years depends on that streak of good management continuing. Click Here for the complete Story[PDF Format]
  • Review Far Eastern EconomicReview
    Apr 24, 2003.

    INNOVATION: Indian Drug Companies Crack The U.S. Market
    India's patent-busting drug firms are grabbing a piece of the lucrative U.S. medicine market with their affordable copies of costly drugs. How? By waging court battles with pharmaceutical giants.

    Click Here for the complete Story[PDF Format]
  • Businessworld Businessworld
    Mar 17, 2003.

    Origin Of A Species
    Aurigene is one of its kind. It shows how to get global talent to work in India. Click Here for the complete Story[PDF Format]
  • International Herald Tribune International Herald Tribune
    Feb11, 2003.

    Dr. Reddy looks to next level
    Not content to copy others, firm seeks to develop its own drugs. Click Here for the complete Story[PDF Format]
  • Business World Business World
    January , 2003

    Dr. Reddy's features as the 7th most respected company.

    Click Here for the complete Story[PDF Format]
  • Outlook Money Outlook Money
    October , 2002

    The Value Creator Award for consistently growing shareholder value.

    Click Here for the complete Story[PDF Format]
  • Business World Business World
    October , 2002

    India's pharma leaders discuss how we can be in the global big league.

    Click Here for the complete Story[PDF Format]
  • Far Eastern Economic Review Far Eastern Economic Review
    September 2002

    Far Eastern Economic Review, a leading business magazine in Asia and part of the Dow Jones Group, in conversation with Mr GV Prasad, CEO, Dr. Reddy's on the challenges facing the Company as it continues on its path to globalization.

    Click Here for the complete Story[HTML Format]
  • Business Today Business Today
    September , 2002

    For long entrepreneur-driven, Dr. Reddy's lab is now focussing on building an organisation with leaders at every level. The idea: become a marketing and research powerhouse.

    Click Here for the complete Story[PDF Format]
  • Financial Times Financial Times
    June 6, 2002

    Drugs innovation is just what the Doctor ordered
    "Innovation is where long-term value lies." says Mr. Prasad.

    Click Here for the complete Story[PDF Format]
  • Scrip Magazine Scrip Magazine
    May, 2002

    Dr Anji Reddy put the Indian Pharma not just on the map but onto the New York Stock Exchange.

    Click Here for the complete Story[PDF Format]
  • Business India Business India
    December, 2001

    Dr. Anji Reddy has demonstrated that a highly focussed small pharma company can also play in the big league of drug discoverers.

    Click Here for the complete Story[PDF Format]
  • Global Forbes Global
    December 2001

    Pill factory to the world:
    India's drug industry is growing beyond cheap knockoffs of Western innovation.

    Click Here for the complete Story[PDF Format]
  • Business Today Business Today
    July, 2001

    The Molecule Millionaires - By focussing on drug research, a clutch of avant-garde drug companies is trying to create a new global niche for itself.

    Click Here for the complete Story[PDF Format]